2021-11-16-世界卫生组织-Cervical_cancer_Mozambique_2021_country_profile_1页_64kb

Mozambique Cervical Cancer Profile Summary

Morbidity and Mortality

• Crude cervical cancer incidence rate: 33.1 per 100,000 women.
• Age-standardized incidence rate: 50.2 per 100,000 women.
• Cumulative risk over age 0-74: 5.0%.
• Cervical cancer deaths: 130,000 female deaths in 2019.
• Mortality-to-incidence ratio: 0.72.
• Total female population: 15,620,000 in 2019.

Primary Prevention

• HPV vaccination not included in national vaccination schedule.
• HPV vaccination programme coverage is low, with <1% coverage among girls by age 15 and 5% overall.
• Primary target cohort: Girls, introductory year not specified.
• Risk factors: Tobacco use prevalence among women aged 15+ years is 37%, condom use data not current, HIV incidence not reported.
• Scale of vaccination programme is low (7.44%).

Secondary Prevention

• National cervical cancer screening programme exists, with only Visual Inspection with Acetic Acid (VIA) as the primary test.
• Target age range not specified; only 3% of women aged 15-54 years screened in past 5 years.
• Programmes exist for early detection at primary care, and a referral system from primary to secondary/tertiary care is present.

Treatment and Supportive Care

• National guidelines for cervical cancer management exist.
• Limited radiotherapy and brachytherapy units: 73 radiotherapy units and fewer brachytherapy units (data not fully available).
• Cancer diagnosis and treatment services are scarce: Generally few radiotherapy units, high medical staff shortage, few cancer centers and specialists (e.g., 70% of women screened but limited facilities).
• Palliative care generally not available in public health system; opioid consumption for morphine-equivalence per capita is <1 mg.

WHO Cervical Cancer Elimination Strategy Indicators

• WHO elimination targets for 2030 not detailed, but overall indicators show limited progress in prevention and treatment.